查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1544092

術中神經監測的全球市場

Intraoperative Neuromonitoring
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球術中神經監測市場將達到 55 億美元

術中神經監測的全球市場預計 2023 年為 39 億美元，預計到 2030 年將達到 55 億美元，2023 年至 2030 年複合年成長率為 4.8%。內部資源神經監測是本報告分析的細分市場之一，預計複合年成長率為 3.9%，到分析期結束時將達到 29 億美元。在分析期間，外包術中神經監測領域的複合年成長率預計為 6.0%。

美國市場預估成長11億美元，中國複合年成長率4.6%

預計 2023 年美國術中神經監測市場規模將達 11 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到8.694億美元，2023-2030年分析期間複合年成長率為4.6%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.4% 和 4.2%。在歐洲，德國的複合年成長率預計為 4.9%。

全球術中神經監測市場—主要趨勢與促進因素總結

什麼是術中神經監測？

術中神經監測 (IONM) 是一種在手術期間用於監測神經結構（例如神經、脊髓和大腦部分）功能完整性的技術。透過提供這些結構電活動的即時回饋，IONM 可以幫助外科醫生避免對關鍵神經途徑的損傷，並降低術後神經病變的風險。這項技術對於確保手術安全至關重要，尤其是涉及脊椎、大腦和周邊神經的手術，即使是最輕微的錯誤也可能導致嚴重的併發症。 IONM 的使用變得越來越廣泛，因為它可以改善手術結果、最大限度地降低風險並有助於提高複雜和精細手術的整體安全性。

技術進步如何形塑術中神經監測市場？

技術進步正在顯著塑造術中神經監測市場，特別是透過監測技術、訊號處理以及與手術系統整合方面的創新。先進電生理監測技術的發展，如體感誘發電位（SSEP）、運動誘發電位（MEP）和肌電圖（EMG），擴大了手術期間可監測的神經結構的範圍，使外科醫生能夠提供神經功能的綜合反饋。訊號處理演算法的改進提高了神經監測資料的準確性和可靠性，從而可以更準確地檢測手術期間的潛在問題。此外，IONM 與先進影像處理技術和機器人手術系統的整合進一步提高了神經監測的有效性，並在複雜手術過程中提供更好的可視化和控制。這些技術趨勢顯著提高了手術安全性和治療效果，從而增加了 IONM 在各個手術領域的採用。

為什麼外科手術中對術中神經監測的需求不斷增加？

由於手術複雜性增加、脊椎和神經外科手術發生率上升以及對病人安全的日益重視，手術環境中對術中神經監測的需求不斷增加。隨著外科手術變得更加複雜並涉及更高的風險，即時監測神經結構對於防止意外損傷和確保積極的結果變得至關重要。脊髓疾病、腦腫瘤和周邊神經損傷等通常需要複雜手術介入的疾病的盛行率不斷上升，也推動了對 IONM 的需求，因為它有助於降低術後神經併發症的風險。此外，外科醫生和患者越來越意識到神經監測的好處，越來越多的醫療保健專業人員採用 IONM 作為提高手術安全性的標準技術，也推動了市場的擴張。隨著醫療保健行業繼續優先考慮患者的治療效果並努力最大程度地降低手術風險，預計對術中神經監測的需求將會成長。

推動術中神經監測市場成長的因素有哪些？

術中神經監測市場的成長是由與技術進步、外科手術複雜性增加以及對提高病患安全的重視相關的幾個因素所推動的。主要驅動力之一是神經監測技術的進步，該技術大大擴展了 IONM 在各種外科專業中的功能和應用。脊椎、神經外科和整形外科手術尤其容易出現神經系統併發症，數量不斷增加，也推動了對 IONM 作為確保手術成功的關鍵工具的需求。擴大採用微創手術技術，以及 IONM 與機器人和導航工具等先進手術系統的持續整合，也透過提高手術精度和安全性進一步推動市場成長。此外，對降低醫療成本和改善患者治療效果的日益關注正在推動 IONM 作為預防措施的採用，以避免代價高昂的術後併發症。由於這些因素繼續影響手術前景，在手術過程中需要更先進、更可靠的全面覆蓋的推動下，市場前景將持續成長，因此需要一個全面的監測解決方案。

受訪企業範例（共46家）

  • Cadwell Industries, Inc.
  • Computational Diagnostics, Inc.
  • Medtronic PLC
  • Natus Medical, Inc.
  • NuVasive, Inc.
  • SpecialtyCare

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP12826

Global Intraoperative Neuromonitoring Market to Reach US$5.5 Billion by 2030

The global market for Intraoperative Neuromonitoring estimated at US$3.9 Billion in the year 2023, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Insourced Intraoperative Neuromonitoring, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.9 Billion by the end of the analysis period. Growth in the Outsourced Intraoperative Neuromonitoring segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 4.6% CAGR

The Intraoperative Neuromonitoring market in the U.S. is estimated at US$1.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$869.4 Million by the year 2030 trailing a CAGR of 4.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Intraoperative Neuromonitoring Market - Key Trends & Drivers Summarized

What Is Intraoperative Neuromonitoring and Why Is It Crucial for Surgical Safety?

Intraoperative neuromonitoring (IONM) is a technique used during surgeries to monitor the functional integrity of neural structures such as nerves, spinal cord, and parts of the brain. By providing real-time feedback on the electrical activity of these structures, IONM helps surgeons avoid injury to critical neural pathways, thereby reducing the risk of postoperative neurological deficits. This technique is crucial for surgical safety, especially in procedures involving the spine, brain, and peripheral nerves, where even a minor error can lead to significant complications. The use of IONM has become increasingly widespread as it enhances surgical outcomes, minimizes risks, and contributes to the overall safety of complex and delicate procedures.

How Are Technological Advancements Shaping the Intraoperative Neuromonitoring Market?

Technological advancements are significantly shaping the intraoperative neuromonitoring market, particularly through innovations in monitoring techniques, signal processing, and integration with surgical systems. The development of advanced electrophysiological monitoring techniques, such as somatosensory evoked potentials (SSEPs), motor evoked potentials (MEPs), and electromyography (EMG), is expanding the range of neural structures that can be monitored during surgery, providing surgeons with comprehensive feedback on neural function. Improvements in signal processing algorithms are enhancing the accuracy and reliability of neuromonitoring data, enabling more precise detection of potential issues during surgery. Additionally, the integration of IONM with advanced imaging technologies and robotic surgical systems is further enhancing the effectiveness of neuromonitoring, allowing for better visualization and control during complex procedures. These technological trends are driving the adoption of IONM across various surgical disciplines, as they offer significant improvements in surgical safety and outcomes.

Why Is There an Increasing Demand for Intraoperative Neuromonitoring in Surgical Practices?

The demand for intraoperative neuromonitoring is increasing in surgical practices due to the growing complexity of surgeries, the rising incidence of spinal and neurosurgical procedures, and the increasing emphasis on patient safety. As surgical procedures become more advanced and involve higher risks, the need for real-time monitoring of neural structures has become essential to prevent inadvertent damage and ensure positive outcomes. The rising prevalence of conditions such as spinal disorders, brain tumors, and peripheral nerve injuries, which often require complex surgical interventions, is also driving demand for IONM, as it helps reduce the risk of postoperative neurological complications. Additionally, the growing awareness of the benefits of neuromonitoring among surgeons and patients is contributing to the market’s expansion, as more healthcare providers adopt IONM as a standard practice to enhance surgical safety. As the healthcare industry continues to prioritize patient outcomes and minimize surgical risks, the demand for intraoperative neuromonitoring is expected to grow.

What Factors Are Driving the Growth in the Intraoperative Neuromonitoring Market?

The growth in the intraoperative neuromonitoring market is driven by several factors related to technological advancements, the increasing complexity of surgical procedures, and the emphasis on improving patient safety. One of the primary drivers is the advancement in neuromonitoring technologies, which has significantly expanded the capabilities and applications of IONM in various surgical specialties. The rising number of spinal, neurosurgical, and orthopedic procedures, which are particularly prone to neural complications, is also fueling demand for IONM as a critical tool for ensuring surgical success. The growing adoption of minimally invasive surgical techniques and the integration of IONM with advanced surgical systems, such as robotics and navigation tools, are further propelling market growth by enhancing the precision and safety of surgeries. Additionally, the increasing focus on reducing healthcare costs and improving patient outcomes is driving the adoption of IONM as a preventive measure to avoid costly postoperative complications. As these factors continue to influence the surgical landscape, the intraoperative neuromonitoring market is expected to experience sustained growth, driven by the need for more advanced, reliable, and comprehensive monitoring solutions during surgery.

Select Competitors (Total 46 Featured) -

  • Cadwell Industries, Inc.
  • Computational Diagnostics, Inc.
  • Medtronic PLC
  • Natus Medical, Inc.
  • NuVasive, Inc.
  • SpecialtyCare

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Intraoperative Neuromonitoring - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Emphasis on Patient Safety Spurs Adoption of Intraoperative Neuromonitoring (IONM)
    • Advancements in Neuromonitoring Technologies Propel Market Growth
    • Shift Towards Minimally Invasive Surgeries Expands Market Opportunities for IONM
    • Technological Innovations Enhance the Accuracy and Reliability of Neuromonitoring
    • Increasing Use of IONM in Complex Spinal and Neurosurgical Procedures
    • Role of Intraoperative Neuromonitoring in Reducing Postoperative Complications
    • Growing Importance of Multimodal Monitoring Techniques in Surgery
    • Advancements in Real-Time Data Analysis and Interpretation Boost Market Adoption
    • Impact of Regulatory Standards and Guidelines on the Adoption of IONM
    • Expansion of IONM in Cardiovascular and Orthopedic Surgeries
    • Role of IONM in Enhancing Outcomes in Pediatric and Geriatric Surgery
    • Growing Demand for Remote Monitoring and Tele-IONM Services
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intraoperative Neuromonitoring Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intraoperative Neuromonitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Intraoperative Neuromonitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Insourced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Insourced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Insourced by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Outsourced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Outsourced by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Outsourced by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • JAPAN
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • CHINA
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • EUROPE
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Intraoperative Neuromonitoring by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Intraoperative Neuromonitoring by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • FRANCE
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • GERMANY
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Rest of Europe Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Rest of Europe 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Intraoperative Neuromonitoring Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Asia-Pacific Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Asia-Pacific 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 47: Rest of World Recent Past, Current & Future Analysis for Intraoperative Neuromonitoring by Type - Insourced and Outsourced - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of World Historic Review for Intraoperative Neuromonitoring by Type - Insourced and Outsourced Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of World 16-Year Perspective for Intraoperative Neuromonitoring by Type - Percentage Breakdown of Value Sales for Insourced and Outsourced for the Years 2014, 2024 & 2030

IV. COMPETITION